Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial
The APPLE COPD-ICON2 trial is a prospective 2×2 factorial, double-blinded proof-of-concept randomised controlled trial targeting patients with chronic obstructive pulmonary disease (COPD) without prior history of cardiovascular disease. The primary goal of this trial is to investigate if treatment w...
Main Authors: | Vijay Kunadian, Nina Wilson, Deborah D. Stocken, Hani Ali, Elaine McColl, Graham Burns, Nicola Howe, Andrew Fisher, Anthony De Soyza, Trial management group, Deborah Stocken, Sean Scott, Jared Thornton, Lesley Hall, Alexander von Wilamowitz-Moellendorff, Andrea Bell, Eva-Maria Holstein, Laura Robertson, Cath Brennand, Jaki Begum |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2019-08-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/5/3/00110-2019.full |
Similar Items
-
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis.
by: Stuart McPherson, et al.
Published: (2017-01-01) -
A psychosocial intervention for the management of functional dysphonia: complex intervention development and pilot randomised trial
by: Vincent Deary, et al.
Published: (2018-02-01) -
Tailoring antiplatelet therapy in older patients with coronary artery disease
by: Mila Kovacevic, et al.
Published: (2023-12-01) -
Midwives' survey of their weight management practice before and after the GLOWING guideline implementation intervention: A pilot cluster randomised controlled trial.
by: Nicola Heslehurst, et al.
Published: (2023-01-01) -
Die „Witterungslehre für den Feldbau“ von Guiseppe Toaldo 1774 — das erste umfassende agrarmeteorologische Fachbuch
by: T. von Wilamowitz-Moellendorff
Published: (1994-03-01)